Is Hard Failure Still a Common Indication for Revision Surgery in Adult Cochlear Implant Recipients?


Journal

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504

Informations de publication

Date de publication:
03 2019
Historique:
entrez: 12 2 2019
pubmed: 12 2 2019
medline: 26 2 2020
Statut: ppublish

Résumé

STUDY DESIGN:: Retrospective chart review. Single tertiary care center, 2001 to 2016. Adult CI recipients were assessed. Inclusion required ≥1 revision surgeries, operative note(s), and postrevision follow-up of 6 months. Therapeutic/rehabilitative. Indications for revision (HF, SF, WC, and MM) were tabulated. The incidence of each was compared between cohorts implanted before/after 2011. Additional outcomes included implant usage, explantation rates, and postrevision speech scores. Four hundred thirty-two patients received 512 CIs. Of these, 30 patients required 38 revisions. Median time to revision was 24.5 months. Frequency by indication was HF (n = 14), SF (n = 12), WC (n = 8), and MM (n = 4). The overall revision rate was 7.4%. There was a significant decline in overall revisions for patients implanted before/after 2011 (10.4 versus3.5%; p = 0.009). No patients implanted after 2011 experienced a HF (p = 0.002). Patients with WC/MM had significantly shorter time to revision compared with patients with HF/SF (p = 0.04). The overall median follow-up was 24 months. Twenty-three of 30 patients are still using their revised CI. Patients revised for HF and MM achieved the best outcomes. 7.4% of adult CI recipients required revision surgery. Explantation/immediate reimplantation was an effective management strategy. While HF was the most common indication overall, no patients implanted after 2011 have suffered this complication. The overall revision rate has significantly declined since 2011.

Identifiants

pubmed: 30741895
doi: 10.1097/MAO.0000000000002118
pii: 00129492-201903000-00011
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

321-327

Auteurs

Shawn M Stevens (SM)

Arizona Otolaryngology Consultants and Barrow Neurologic Institute, University of Cincinnati, Phoenix, Arizona.

Hayden Dougherty (H)

Department of Communication Sciences and Disorders.

Lisa Wenstrup (L)

Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati, Cincinnati, Ohio.

Theresa Hammer (T)

Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati, Cincinnati, Ohio.

Tyler Cole (T)

Department of Neurosurgery, Barrow Neurologic Institute, Phoenix, Arizona.

Andrew Redmann (A)

Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati and Cincinnati Childrens, Cincinnati, Ohio.

Myles L Pensak (ML)

Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati, Cincinnati, Ohio.

Ravi N Samy (RN)

Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati (UC) College of Medicine and Neurosensory Disorders Center at UC Gardner Neuroscience Institute, University of Cincinnati, Cincinnati, Ohio.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH